These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38403546)

  • 21. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroglobin functions as a prognostic marker and promotes the tumor growth of glioma via suppressing apoptosis.
    Zhang B; Chang M; Wang J; Liu Y
    Biomed Pharmacother; 2017 Apr; 88():173-180. PubMed ID: 28103511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in brainstem gliomas.
    Cohen ME; Duffner PK; Heffner RR; Lacey DJ; Brecher M
    Neurology; 1986 May; 36(5):602-5. PubMed ID: 3703258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Low malignancy grade glioma in the Uppsala++/Orebro region. Prognostic factors and survival among 119 patients].
    Ribom D; Adner J; Eriksson A; Persson L; Smits A
    Lakartidningen; 2000 Sep; 97(36):3880-4. PubMed ID: 11036338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD44 and the survival in glioma: a meta-analysis.
    Wu G; Song X; Liu J; Li S; Gao W; Qiu M; Yang C; Ma Y; Chen Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse brainstem tumors: when is a biopsy necessary?
    Albright AL
    Pediatr Neurosurg; 1996; 24(5):252-5. PubMed ID: 8933568
    [No Abstract]   [Full Text] [Related]  

  • 27. Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical Prognosis.
    Liu MF; Hu YY; Jin T; Xu K; Wang SH; Du GZ; Wu BL; Li LY; Xu LY; Li EM; Xu HX
    Dis Markers; 2015; 2015():138974. PubMed ID: 26663949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis.
    Liu Y; Xu Z; Jin T; Xu K; Liu M; Xu H
    Med Sci Monit; 2020 Jun; 26():e921947. PubMed ID: 32484805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway.
    Li J; Gong LY; Song LB; Jiang LL; Liu LP; Wu J; Yuan J; Cai JC; He M; Wang L; Zeng M; Cheng SY; Li M
    Am J Pathol; 2010 Feb; 176(2):699-709. PubMed ID: 20035051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
    Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
    Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating glioma biomarkers.
    Kros JM; Mustafa DM; Dekker LJ; Sillevis Smitt PA; Luider TM; Zheng PP
    Neuro Oncol; 2015 Mar; 17(3):343-60. PubMed ID: 25253418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression level of human miR-34a correlates with glioma grade and prognosis.
    Gao H; Zhao H; Xiang W
    J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An artificial neural network model based on DNA damage response genes to predict outcomes of lower-grade glioma patients.
    Chen J; Qian X; He Y; Han X; Pan Y
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34015817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
    Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S
    J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients.
    Lim J; Kim MJ; Park Y; Ahn JW; Hwang SJ; Moon JS; Cho KG; Kwack K
    Sci Rep; 2019 May; 9(1):7895. PubMed ID: 31133717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis.
    Liu MF; Jin T; Shen JH; Shen ZY; Zheng ZC; Zhang ZL; Xu LY; Li EM; Xu HX
    J Neurooncol; 2011 Aug; 104(1):119-27. PubMed ID: 21184133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
    Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
    J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and Overview of Gliomas.
    Davis ME
    Semin Oncol Nurs; 2018 Dec; 34(5):420-429. PubMed ID: 30392758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.